基本信息
浏览量:68
职业迁徙
个人简介
Dr. Nuermberger’s primary research interest is the experimental chemotherapy of TB. The work uses validated murine models of active TB and latent TB infection to evaluate the efficacy of promising new drugs and drug regimens. A major goal is to identify new agents that can be combined together in novel regimens or combined with existing drugs to shorten the duration of TB therapy.
A newer interest is to develop improved animal models of non-tuberculous mycobacterial infection to enable a similar approach to drug and regimen development for these difficult-to-treat infections.
研究兴趣
论文共 251 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lourdes Encinas,Si-Yang Li,Joaquin Rullas-Trincado,Rokeya Tasneen,Sandeep TYAGI,Heena Soni,Adolfo Garcia-perez,Jin Lee,Rubén González del Río, Jaime De Mercado,Verónica Sousa, Izidor Sosi?,
biorxiv(2024)
bioRxiv : the preprint server for biologyno. 7 (2023)
EUROPEAN RESPIRATORY JOURNALno. 2 (2023): 2300165-2300165
Antimicrobial agents and chemotherapyno. 4 (2023)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 3 (2023)
Abigail Marie Klever, Kathleen A. Alexander,Deepak Almeida,Matthew Z. Anderson, Ray L. Ball,Gillian Beamer, Paola Boggiatto,Jane E. Buikstra, Bruce Chandler,Tiffany A. Claeys, Aislinn E. Concha,Paul J. Converse,
Tuberculosis (Edinburgh, Scotland) (2023): 102377-102377
Kamunkhwala Gausi,Soyeon Kim, Ryan Wu, Xin Sun,Elisa Ignatius,Laura Moran,Veronique De Jager, Yvetot Joseph,Samuel Pierre,Susan Rosenkranz,Susan Swindells,Eric Nuermberger,
BRITISH JOURNAL OF PHARMACOLOGY (2023): 331-332
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn